Prophylactic effect of phenytoin in bipolar disorder: A controlled study

Bipolar Disorders

Volumn 5, Issue 6, 2003, Pages 464-467

  Mishory, A ^a   Winokur, M ^b   Bersudsky, Yuly ^b  

^a Barzilai Hospital   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Bipolar disorder; Phenytoin; Prophylactic

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; PHENYTOIN; PLACEBO; VALPROIC ACID; VENLAFAXINE;

ADULT; BIPOLAR DISORDER; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HUMAN; MALE; MOOD DISORDER; MUSCLE WEAKNESS; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RELAPSE; REVIEW; SOMNOLENCE; STATISTICAL ANALYSIS; SURVIVAL RATE; VERTIGO;

ANTICONVULSANTS; BIPOLAR DISORDER; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENYTOIN; RECURRENCE; TREATMENT OUTCOME;

EID: 0347286967     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-5618.2003.00070.x     Document Type: Review

References (18)

1. Bowden CL. Novel treatments for bipolar disorder. Expert Opin Investig Drugs 2001; 10: 661-71.
2. Bowden C, Calabrese J, McElroy S et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000; 57: 481-489.
3. Bowden C, Calabrese J, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60: 392-400.
4. Mitchell PB, Malhi GS. The expanding pharmacopoeia for bipolar disorder. Annu Rev Med 2002; 53: 173-188.
5. Macdonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia 1995; 36(Suppl. 2): S2-12.
6. Post RM. Use of anticonvulsants in the treatment of manic-depressive illness. In: Pippenger CE ed. Clinical Use of Anticonvulsants in Psychiatric Disorders. New York: Demos Publications, 1989: 113-152.
7. Kalinowsky LB, Putnam TJ. Attempts at treatment of schizophrenia and other non-epileptic psychoses with Dilantin. Arch Neurol Psychiatry 1943; 49: 414-420.
8. Devinsky O. Cognitive and behavioral effects of antiepileptic drugs. Epilepsia 1995; 36(Suppl. 2): S46-65.
9. Mishory A, Yaroslavsky Y, Bersudsky Y, Belmaker RH. Phenytoin as an antimanic anticonvulsant: a controlled study. Am J Psychiatry 2000; 157: 463-465.
10. Overall J, Gorham D. The brief psychiatric rating scale. Psychol Rep 1962; 10: 799-812.
11. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-35.
12. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
13. Guy W. Assessment Manual for Psychopharmacology. US Department of Health, Education and Welfare publication 1976: 218-222.
14. Cox DR. Some applications of exponential ordered scores. J of the Royal Statistical Society 1964; 26: 103-110.
15. Lee ET. Statistical Methods for Survival Data Analysis. Belmont, CA: Lifetime Learning Publications, 1980.
16. Laska EM, Klein DF, Lavori PW, Levine J, Robinson DS. Design issues for the clinical evaluation of psychotropic drugs. In: Prien RF, Robinson DS eds. Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines, American College of Neuropsychopharmacology. New York: Raven Press, 1994: 29-67.
17. Levine J, Bersudsky Y, Nadri C et al. Mechanism of action of new mood stabilizing drugs. In: Gershon S ed. Handbook of Medical Psychiatry. New York: Marcel Dekker, Inc., 2003: 793-807.
18. Applebaum J, Levine J, Belmaker R. Intravenous fosphenytoin in acute mania. J Clin Psychiatry 2003; 64: 408-409.